首页> 外文期刊>Endocrine journal >A New Point Mutation (3426, A to G) in Mitochondrial NADH Dehydrogenase Gene in Korean Diabetic Patients Which Mimics 3243 Mutation by Restriction Fragment Length Polymorphism Pattern
【24h】

A New Point Mutation (3426, A to G) in Mitochondrial NADH Dehydrogenase Gene in Korean Diabetic Patients Which Mimics 3243 Mutation by Restriction Fragment Length Polymorphism Pattern

机译:韩国糖尿病患者线粒体NADH脱氢酶基因的新点突变(3426,从A到G),通过限制性片段长度多态性模式模拟3243突变

获取原文
       

摘要

References(20) Cited-By(6) Mitochondrial TrnaLeu(UUR) gene mutation is one of the candidates in the pathogenesis of NIDDM. Especially the 3243 (A→G) mutation is associated with the maternally-inherited diabetes and deafness. To evaluate the prevalence and characteristics of the 3243 point mutation in Koreans, we screened 433 Korean diabetic patients (220 men and 213 women). Genomic DNA was extracted from peripheral white blood cells and PCR was carried out with mitochondrial DNA primers (3130-3149, 3558-3539) encompassing the 3243 position. After digestion with Apa-1, five subjects showed polymorphism suggesting 3243 point mutation but when we directly sequenced the amplified DNA with an automatic sequencer, only 2 of the 5 patients were shown to have 3243 (A→G) mutation and the other 3 subjects had 3426 (A→G) mutation rather than 3243 mutation. Two diabetic patients with 3243 mutation were lean (BMI=14.4, 17.0kg/m2), had relatively lower fasting C-peptide concentrations (0.9 ng/ml each), and required insulin for management. In contrast, those with 3426 point mutation were not lean (BMI=22.6-28.0kg/m2), had relatively higher C-peptide levels (3.9-5.4ng/ml), and could be managed with oral hypoglycemic agents. None of the 5 patients had deafness. In conclusion, the prevalence of 3243 point mutation in Korean diabetic patients was approximately 0.5% and we found a new mutation mimicking 3243 mutation by PCR-RFLP (restriction fragment length polymorphism) pattern. We suggest that sequencing of the PCR product or designing smaller PCR fragment size to enhance the specificity may help to identify the exact location of the point mutation.
机译:参考文献(20)被引用的By(6)线粒体TrnaLeu(UUR)基因突变是NIDDM发病机制中的候选基因之一。特别是3243(A→G)突变与母亲遗传的糖尿病和耳聋有关。为了评估韩国人3243点突变的发生率和特征,我们筛选了433名韩国糖尿病患者(男性220例,女性213例)。从外周血白细胞中提取基因组DNA,并用围绕3243位的线粒体DNA引物(3130-3149、3558-3539)进行PCR。用Apa-1消化后,有5名受试者表现出多态性,表明3243点突变,但是当我们使用自动测序仪直接对扩增的DNA进行测序时,这5名患者中只有2名表现出3243(A→G)突变,其他3名受试者具有3426(A→G)突变而不是3243突变。两名患有3243突变的糖尿病患者瘦(BMI = 14.4,17.0kg / m2),空腹C肽浓度相对较低(每人0.9 ng / ml),并且需要胰岛素治疗。相比之下,具有3426点突变的人则不瘦(BMI = 22.6-28.0kg / m2),具有相对较高的C肽水平(3.9-5.4ng / ml),可以通过口服降糖药进行治疗。 5例患者均无耳聋。总之,在韩国糖尿病患者中3243点突变的患病率约为0.5%,我们通过PCR-RFLP(限制性片段长度多态性)模式发现了一个模拟3243突变的新突变。我们建议对PCR产物进行测序或设计较小的PCR片段以增强特异性可能有助于鉴定点突变的确切位置。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号